摘要
本文从伏立诺他作为HDAC抑制剂的用途入手,针对伏立诺他的相关专利文献进行了统计分析,从申请趋势、技术来源国、专利申请目标国、重要申请人、专利权终属公司、重要专利申请等方面对伏立诺他相关专利的特点进行归纳总结,着重分析了重要专利申请的特点,同时梳理了伏立诺他化合物原研方及上市药物研发方的专利申请路线,以期为国内药物研发企业制定研发策略、进行专利布局提供参考和借鉴。
This paper provides a brief introduction to the patent protection of the HDAC inhibitor Vorinostat, such as the application trend, the country of origin of the technology, the target countries of the patent applications, the important patent applicants, the companies of patent ownership, and important patent applications, focuses on the characteristics of important patent applications, and introduces the patent information of the original researcher and the marketed drug researcher of Vorinostat. Based on the information above,some suggestions are made to provide reference for pharmaceutical development and intellectual property rights utilization and management of Chinese pharmaceutical companies.
作者
原悦
迟丽娜
周付科
郭晓赟
王勤耕
YUAN Yue;CHI Lina;ZHOU Fuke;GUO Xiaoyun;WANG Qingeng(Patent Examination Cooperation (Beijing) Center of the Patent Office,CNIPA,Beijing 100160)
出处
《中国发明与专利》
2019年第6期119-124,共6页
China Invention & Patent
